The poster presentations will highlight Domain's progress in leveraging GPCR-targeting therapies to ... DT-7012 – A Differentiated CCR8-Depleting Antibody for Solid Tumors DT-7012 is a highly ...

Employing its deep understanding of G-protein coupled receptors (GPCRs) the Beacon Discovery team has delivered more than 20 compounds into clinical development over the past two decades ...

The poster presentations will highlight Domain's progress in leveraging GPCR-targeting therapies to modulate the tumor microenvironment and enhance anti-cancer immune responses. DT-7012 – A ...